Guillaume Eberst

Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer

Caroline Laheurte, Magalie Dosset, Déwi Vernerey et al. · British Journal of Cancer · 2019 · 94 citations · Full text

Life Sciences, Immunology, Oncology +17

Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

Guillaume Eberst, Fréderic Claudé, Lucie Laurent et al. · Annals of Intensive Care · 2022 · 72 citations · Full text

Medicine, Infectious Diseases, Acute Care Medicine +10

Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

Guillaume Eberst, Déwi Vernerey, Caroline Laheurte et al. · BMC Cancer · 2022 · 42 citations · Full text

Medicine, Hematology, Oncology +15

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study

Olivier Adotévi, Déwi Vernerey, P. Jacoulet et al. · Journal of Clinical Oncology · 2022 · 41 citations

Medicine, Immunology, Oncology +16

Circulating NKp46⁺Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer

Émilie Picard, Yann Godet, Caroline Laheurte et al. · OncoImmunology · 2018 · 33 citations · Full text

Life Sciences, Immunology, Oncology +13